What does LLUS mean?
LLUS means Late leakage of undetermined source
This acronym/slang usually belongs to Medical & Science category.
What is the abbreviation for Late leakage of undetermined source?
Late leakage of undetermined source can be abbreviated as LLUS
|
|
Most popular questions people look for before coming to this page
Q: A: |
What does LLUS stand for? LLUS stands for "Late leakage of undetermined source". |
Q: A: |
How to abbreviate "Late leakage of undetermined source"? "Late leakage of undetermined source" can be abbreviated as LLUS. |
Q: A: |
What is the meaning of LLUS abbreviation? The meaning of LLUS abbreviation is "Late leakage of undetermined source". |
Q: A: |
What is LLUS abbreviation? One of the definitions of LLUS is "Late leakage of undetermined source". |
Q: A: |
What does LLUS mean? LLUS as abbreviation means "Late leakage of undetermined source". |
Q: A: |
What is shorthand of Late leakage of undetermined source? The most common shorthand of "Late leakage of undetermined source" is LLUS. |
Abbreviations or Slang with similar meaning
- ACGUS - Atypical Glandular Cells of Undetermined Significance
- AGCUS - Atypical Glandular Cells of Undetermined Significance
- ASCUS/SIL - Atypical squamous cells of undetermined significance/squamous intraepithelial lesion
- ASQUS - atypical squamous cells of undetermined significance
- LEAIQ - Late Effect of Accidental Injury Questionnaire
- MLUS - Monoclonal Lymphocytosis of Undetermined Significance
- MoUC - Method of Undetermined Coefficients
- CAOS - Commercial Adoption of Open Source
- LEOP - Late Effects of Polio
- LOF - Leakage of Fluid
- LOPD - Late Onset of Parkinson's Disease
- LPVA - Late Potentials of Ventricular Activation
- AMOS - Automated Matching of Open Source
- L-LTP - late phase of long-term potentiation
- LSP - late sequelae of poliomyelitis
- LTP - late termination of pregnancy
- OSP - Of Open Source Physics
- ASCUS - atypia of squamous cells of undetermined significance
- LATE - Late Assessment of Thrombolytic Efficacy
- LATE - Late Assessment of Thrombolytic Efficace